ArticleScientific reports2025
Drug screening in pharmaceutical and forensic applications using extractive-liquid sampling electron ionization-mass spectrometry (E-LEI-MS).
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In a wide range of fields, including the pharmaceutical industry and forensic science, obtaining real-time results is paramount. Hence, new analytical techniques are being developed to be both simple and fast, providing results in a few minutes. Extractive-liquid Sampling Electron Ionization-Mass Spectrometry (E-LEI-MS) is proposed as a novel analytical approach that combines an ambient sampling with the high identification power of electron ionization, providing the results in less than five minutes. E-LEI-MS was employed to analyze 20 industrial drugs belonging to different therapeutic classes and pharmaceutical forms, to evaluate its ability to detect active pharmaceutical ingredients and excipients. All samples were analyzed without any pre-treatment. Additionally, the system was coupled to high-resolution MS and used to analyze 20 benzodiazepines. Among them, the six most commonly marketed benzodiazepines were used for cocktail fortification and analyzed as a residue on a glass surface to simulate the forensic scenario of benzodiazepines being used as rape drugs, where glass represents a crime scene sample. The accurate identification of these compounds demonstrates that E-LEI-MS can serve as a valuable screening technique in applications requiring the rapid acquisition of qualitative data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.